ClinicalTrials.gg
CompletedNCT07838272ERAC-XRUpdated Sep 24, 2026

Enhancing Emotion Regulation in Children With Autism Through Extended Reality

An interventional study of Extended Reality and Emotion regulation coaching in Autism and Emotion Regulation Difficulties, sponsored by Johannes Kepler University of Linz. Completed at 1 site in Austria. Open to participants aged 9 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Johannes Kepler University of Linz · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Feb 2026, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
9 Years to 15 Years
Sex
All
01

Study summary

Pilot study on the development of an Extended Reality (XR) application to support emotion regulation in children with Autism Spectrum Disorder (ASD) (random assignment to an experimental group, N = 10, and a control group, N = 10).

The matched control group with autistic children of the same age receives emotion regulation coaching without the use of virtual reality.

Few studies systematically captured the transfer of XR-supported learning into real life. One study investigated the transfer of breathing techniques into everyday life, where children with ASD successfully transferred these techniques to daily life and applied learned breathing patterns in anxiety-inducing situations. The use of XR systems is considered as low-risk.

Primary Hypotheses:

  • Feasibility analysis of the described XR-supported coaching
  • Reduced Emotional Dysregulation between T1 and T2

Secondary Hypotheses:

  • Reduced Parental stress between T1 and T2
  • Reduced internalising/externalising behaviors between T1 and T2
  • Exploratory analyses of physiological parameter changes during intervention period
Read the detailed description

The majority of children with autism experience significant challenges in the domain of emotion regulation. These difficulties frequently result in conflict situations, bullying, school refusal, and increased stress for the child's social environment, particularly within the family and school context. Common therapeutic and coaching-oriented interventions are typically based on cognitive-behavioral therapy (CBT) approaches and include psycho-education, exposure techniques, and skills training. However, CBT-based interventions in children with ASD often yield only modest long-term effects. This limitation is partly attributed to the restricted generalisation of skills acquired within therapeutic settings to diverse/unpredictable real-life situations . Realistic and adaptive learning environments are therefore of critical importance for optimising learning outcomes in children with ASD-an opportunity increasingly enabled by technological advances in Virtual and Extended Reality systems.

Extended Reality (XR) is an umbrella term encompassing Virtual Reality (VR; fully immersive visual experiences), Augmented Reality (AR; real-world experiences enhanced with virtual or auditory stimuli), and the integration of biosignal parameters. High-quality simulations that allow for a substantial degree of immersion in the virtual environment are considered essential for generating therapeutically effective experiences and facilitating the internalisation of adaptive strategies.

In addition, digitally designed and gamified elements can enhance motivation-particularly in the acquisition of emotion regulation strategies, which are often associated with negative emotional experiences. Another notable advantage is that potentially hazardous real-life situations, such as crossing a street, can be practiced safely and in a stepwise, adaptive manner within XR environments.

To date, XR applications have primarily focused on training isolated skills, especially social competencies and emotion recognition. Only a limited number of studies have reported standardised outcome measures, sample sizes remain small, no formal guidelines for XR implementation currently exist, and independent replication trials of specifically developed XR paradigms are lacking. Recent technological advances, however, offer substantial potential for the development of standardised and methodologically comparable applications across independent clinical and research settings.

Few studies have systematically examined the transfer of XR-acquired skills into everyday life. One study investigated the transfer of breathing techniques into daily contexts and found that children with ASD successfully applied learned breathing patterns in anxiety-provoking situations. The use of XR systems is generally considered low-risk. In some cases, symptoms of "cybersickness" (e.g., nausea, dizziness, headaches) may occur; however, individual risk and symptom manifestation can be systematically assessed before and during application

02

Conditions studied

  • Autism
  • Emotion Regulation Difficulties

Keywords

  • Autism
  • Emotion Regulation
  • Extended Reality
  • Virtual Reality
  • Intervention Study
03

In context

Autistic Disorder

1,033 studies on the registry are indexed under Autistic Disorder; 269 are open to participants now.

This study's enrollment of 24 is below the median of 49 across 813 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

Johannes Kepler University of Linz is the lead sponsor of 34 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of Autism Spectrum Disorder (ASD), without sensory impairments.
  • Sufficient German language proficiency of both children and parents to enable participation in the training (German instructions and explanations) and valid completion of questionnaires.
  • Inclusion of children presenting with behavioral problems.

Exclusion criteria

Exclusion Criteria:

  • Children whose families do not consent to anonymized data processing.
  • Children whose families do not consent to the transmission of video-based recordings of everyday stressors for integration into the XR training.
  • Children with an IQ \< 85.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Emotion-Regulation supported through Extended Reality

    Experimental-group will experience emotion-regulation-coaching plus extended-reality exposure to intensively train emotion-regulation strategies

    Behavioral: Extended Reality · Behavioral: Emotion regulation coaching

  • Active comparator
    Control group gets training without extended reality exposure

    The age-matched control group will receive a comparable emotion-regulation-coaching but not additionally extended reality exposure

    Behavioral: Emotion regulation coaching

Interventions

  • BehavioralExtended Reality

    Extended Reality exposure will be additionally used to train children in using emotion regulation techniques during stressful daily life situations

  • BehavioralEmotion regulation coaching

    Emotion regulation training based on worksheets, exercises and education

06

What researchers measure

Primary outcomes

  1. Feasibility of XR-environment usage during emotion regulation training with autistic children

    Self constructed feedback-questionnaire for a) parents and b) children with ratings on a 4-point Likert-scale (min=1, max=4) respectively: * Experimental and Control-group * 13 questions on emotion-coaching and study organisation * Experimental group additionally: --\> 13 XR-specific items for evaluating VR-specific experiences. * Higher scores can mean better or worse (explanation and description when reported) * Descriptive reports on group-mean-scores of single-items

    Time frame: End of treatment at 6 weeks

  2. Cybersickness Questionnaire in Virtual Reality (CSQ-VR)

    German, unvalidated, adapted version, self reported through child with ratings on a 7-point Likert-scale (min=1, max=7). * Experimental group only * 6 questions * higher scores mean worse

    Time frame: After first week of treatment (after first VR-exposure)

  3. Emotion Dysregulation Change (EDI)

    Emotion Dysregulation change for children of both groups using the Emotion Dysregulation Inventory (EDI; parental rated questionnaire with 30 items on a Likert scale 1-5; min=0, max=4) at each time point. Higher scores mean worse The EDI provides 2 scales: Reactivity (24 items) and Dysphoria (6 items).

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Behavior problems

    Parents take daily notes by a self-constructed problem-behavior diary which assesses frequency of occurrence, intensity, support offered by parents, new strategies applied.

    Time frame: From enrollment to the end of treatment at 6 weeks

Secondary outcomes

  1. Parental Stress Change

    Parental stress change between T1(enrollment) and T2 (6weeks) evaluated with Parental Stress Inventory (PSI) which is a parental rated questionnaire providing child- and general-parental related stressors on a 5-point Likert-scale (min=1, max=5); higher means less; scores need to be recoded (e.g. 1=5, 2=4; 3=3; 4=2; 5=1)

    Time frame: From enrollment to the end of treatment at 6 weeks

  2. Spence Children's Anxiety Scale (SCAS)

    Anxiety change of all children between T1 (enrollment) to T2 (6 weeks) using the Spence Children's Anxiety Scale (SCAS), which provides six specific subscales (Obsessive Compulsive Disorder, Social Phobia, Panic Agoraphobia, Separation Anxiety, Physical Injury Fears, Generalised Anxiety) The SCAS is rated by children on a 4-point Likert scale (min=0, max=3; smaller score means less anxiety)

    Time frame: From enrollment to the end of treatment at 6 weeks

  3. Internal and External Probleme Behavior change

    Child's psycho-emotional change between T1 (enrollment) to T2 (6 weeks) according to internal and external problem behavior are assessed by the Strength and Difficulties Questionnaire (SDQ) through parental ratings on a 3-point Likert scale (min=0, max =2; higher means worse).

    Time frame: From enrollment to the end of treatment at 6 weeks

  4. Physiological Parameters

    A biosignal ring (SENSTREAM (c)) was used to measure physiological arousal during coaching sessions. Analyses will use the electrodermal activity as a reliable parameter for arousal levels during physical or mental tasks. The ring was offered (optional use through children who participated in the study) and if agreed - used on the 1st, 3rd and 6th coaching appointment. Exploratory analyses compare mean-scores between theses 3 time points.

    Time frame: From enrollment to the mid (week 3) and end of treatment at 6 weeks

07

Study locations

1 site
  • Autismuskompetenzzentrum - Hospital of St.John of God
    Linz, Upper Austria 4020, Austria
08

References and documents

Publications

  • Vasarainen, M., Paavola, S., & Vetoshkina, L. (2021). A systematic literature review on extended reality: Virtual, augmented and mixed reality in working life. International Journal of Virtual Reality, 21(2), 1-28. DOI: 10.20870/IJVR.2021.21.2.4620
  • Toma MV, Turcu CE, Turcu CO, Vlad S, Tiliute DE, Pascu P. Extended Reality-Based Mobile App Solutions for the Therapy of Children With Autism Spectrum Disorders: Systematic Literature Review. JMIR Serious Games. 2024 Feb 19;12:e49906. doi: 10.2196/49906. PubMed 38373032 ↗
  • Lorenzo, G. G., Newbutt, N. N., & Lorenzo-Lledó, A. A. (2023). Designing virtual reality tools for students with Autism Spectrum Disorder: A systematic review. Education and Information Technologies, 28(8), 9557-9605. DOI: 10.1007/s10639-022-11545-z
  • Ip, H. H., Wong, S. W., Chan, D. F., Byrne, J., Li, C., Yuan, V. S., ... & Wong, J. Y. (2018). Enhance emotional and social adaptation skills for children with autism spectrum disorder: A virtual reality enabled approach. Computers & Education, 117, 1-15. DOI: 10.1016/j.compedu.2017.09.010
  • Bossenbroek R, Wols A, Weerdmeester J, Lichtwarck-Aschoff A, Granic I, van Rooij MMJW. Efficacy of a Virtual Reality Biofeedback Game (DEEP) to Reduce Anxiety and Disruptive Classroom Behavior: Single-Case Study. JMIR Ment Health. 2020 Mar 24;7(3):e16066. doi: 10.2196/16066. PubMed 32207697 ↗
  • Beck KB, Conner CM, Breitenfeldt KE, Northrup JB, White SW, Mazefsky CA. Assessment and Treatment of Emotion Regulation Impairment in Autism Spectrum Disorder Across the Life Span: Current State of the Science and Future Directions. Child Adolesc Psychiatr Clin N Am. 2020 Jul;29(3):527-542. doi: 10.1016/j.chc.2020.02.003. Epub 2020 Apr 3. PubMed 32471600 ↗
  • Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, Bakken S, Kaplan CP, Squiers L, Fabrizio C, Fernandez M. How we design feasibility studies. Am J Prev Med. 2009 May;36(5):452-7. doi: 10.1016/j.amepre.2009.02.002. PubMed 19362699 ↗

Individual participant data

Plan to share: No — Data might be shared on request by the responsible author

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2026 to primary completion in Aug 2026, 5 months.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 52. This study's 5 months is below that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2026
First posted
Sep 24, 2026
StartActual
Feb 18, 2026
Primary completionActual
Aug 13, 2026
CompletionActual
Aug 13, 2026
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07838272
Lead sponsor
Johannes Kepler University of Linz
Collaborators
Interdisciplinary Transformation University Austria, Hospital of St.John of God, Linz
Responsible party
Sponsor
First posted
Sep 24, 2026
Start date
Feb 18, 2026
Primary completion
Aug 13, 2026
Completion
Aug 13, 2026
Last update
Sep 24, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion